Clinical Trials Directory

Trials / Completed

CompletedNCT03026257

Clinical Assessment of a HYDRAGLYDE® Regimen

Clinical Assessment of a Regimen of AIR OPTIX® Plus HYDRAGLYDE® Silicone Hydrogel Lenses and HYDRAGLYDE® Containing Lens Care Solutions

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
323 (actual)
Sponsor
Alcon, a Novartis Company · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate worn AIR OPTIX® plus HYDRAGLYDE® (AOHG) lenses cleaned and disinfected with HYDRAGLYDE® containing lens solutions compared to each of the control habitual silicone hydrogel (SiHy) lenses cleaned and disinfected with habitual multi-purpose solution (MPS) for cholesterol uptake.

Conditions

Interventions

TypeNameDescription
DEVICELotrafilcon B contact lenses with added wetting agentSilicone hydrogel contact lenses
DEVICESamfilcon A contact lensesHabitual silicone hydrogel contact lenses
DEVICEPOLYQUAD/ALDOX-preserved contact lens solution with added wetting agentMulti-purpose disinfecting solution for contact lens care
DEVICEHydrogen peroxide-based contact lens solution with added wetting agentSolution for contact lens cleaning and disinfecting
DEVICESenofilcon C contact lensesHabitual silicone hydrogel contact lenses
DEVICESenofilcon A contact lensesHabitual silicone hydrogel contact lenses with a replacement pair issued after 2 weeks
DEVICEComfilcon A contact lensesHabitual silicone hydrogel contact lenses
DEVICEHabitual Multi-Purpose Solution (HMPS)Multi-purpose solution for contact lens care according to participant's habitual brand, used per manufacturer's instructions

Timeline

Start date
2017-02-13
Primary completion
2017-08-18
Completion
2017-08-18
First posted
2017-01-20
Last updated
2018-08-14
Results posted
2018-08-14

Locations

8 sites across 3 countries: United States, Canada, Germany

Regulatory

Source: ClinicalTrials.gov record NCT03026257. Inclusion in this directory is not an endorsement.